Health Desk-- 16 May, 2018: The scientists of United Kingdom believe they may have found a way to combat the common cold.
The treatment targets the human host. It blocks a key protein in the body's cells that cold viruses normally hijack to self-replicate and spread. This should stop any cold virus in its tracks if given early enough, lab studies suggest. Safety trials in people could start within two years.
In the lab, it worked within minutes of being applied to human lung cells, targeting a human protein called NMT, Nature Chemistry journal reports.
The Imperial College London researchers are working on making a form of the drug that can be inhaled, to reduce the chance of side-effects.
Courtesy: BBC Health